Astrid Knott

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis

Cancer Statistics, 2021

Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis

Hepatocellular carcinoma

Incidence and Mortality of Acute‐on‐Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis

How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting

Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

Global burden of liver disease: 2023 update

Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit All

Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels

Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Review: Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Screening for Hepatitis C Virus Infection in Adolescents and Adults

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

EASL Recommendations on Treatment of Hepatitis C 2018

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

All-Cause Mortality and Liver-Related Outcomes Following Successful Antiviral Treatment for Chronic Hepatitis C

Integrated Psychiatric/Medical Care in a Chronic Hepatitis C Clinic: Effect on Antiviral Treatment Evaluation and Outcomes